MDCK-33016,MDCK-33016PF BioVector? cell line犬腎臟上皮細(xì)胞-流感病毒疫苗生產(chǎn)用細(xì)胞株
- 價(jià) 格:¥598950
- 貨 號:BioVector?-MDCK-33016
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作微信:1843439339 (QQ同號)
手機(jī):18901268599
地址:北京
- 已注冊
BioVector? MDCK-33016 Cell Line Datasheet
English Version
1. Cell Line Overview
Cell Line Name: BioVector? MDCK-33016 (also referred to as MDCK-33016PF)
Species of Origin:Canis familiaris (Canine)
Tissue Origin: Kidney
Cell Type: Epithelial
Morphology: Adherent; can be adapted for suspension growth in serum-free media
Parental Line: Derived from the original MDCK (Madin-Darby Canine Kidney) cell line
Deposit Institution: DSM ACC 2219
2. Description and Applications
BioVector? MDCK-33016 is a qualified continuous cell line specifically developed and selected for its high susceptibility to influenza viruses. It is a key substrate for the production of cell-based seasonal and pandemic influenza vaccines, such as the commercial vaccine BioVector? Optaflu?. The cell line supports efficient isolation and propagation of human influenza A and B viruses, often demonstrating higher isolation rates and better antigenic match to circulating strains compared to traditional egg-based methods.
3. Key Features
High Virus Yield: Engineered to support robust replication of influenza viruses.
Vaccine Production: Used in the manufacture of cell culture-derived influenza vaccines.
Regulatory Acceptance: Qualified and validated for use in human vaccine production.
Safety: Multiple, orthogonal purification processes ensure the removal of residual cells and DNA, reducing theoretical risks to effectively zero.
4. Growth and Culture Conditions
Recommended Medium: BioVector? High Salt LB-Miller Medium (for related bacterial work) or specifically formulated serum-free media optimized for BioVector? MDCK-33016 cells. Note that these cells require 1% NaCl and specific formulations for optimal growth.
Growth Characteristics: Cells grow at a controlled rate suitable for vaccine production. Adherent cultures require standard incubation conditions (37°C, 5% CO?).
Suspension Adaptation: The cell line can be adapted to grow in suspension using appropriate serum-free media, facilitating large-scale bioreactor production.
5. Quality Control and Safety
Sterility Testing: Negative for bacteria, fungi, and mycoplasma.
Viral Testing: Extensively tested and confirmed negative for adventitious viral agents and oncogenic viruses.
Tumorigenicity: Like most continuous cell lines, it can form tumors in immunocompromised mice, necessitating rigorous purification of final products.
6. Applications
Isolation and propagation of influenza viruses from clinical specimens
Production of cell culture-derived influenza vaccines (seasonal and pandemic)
Development of candidate vaccine viruses (CVVs)
Reverse genetics systems for influenza virus rescue
Virology research and diagnostic assays
BioVector? MDCK-33016 細(xì)胞系
中文版本
1. 細(xì)胞系概述
細(xì)胞系名稱: BioVector? MDCK-33016(也稱為 MDCK-33016PF)
物種來源: 犬 (Canis familiaris)
組織來源: 腎臟
細(xì)胞類型: 上皮細(xì)胞
形態(tài)特征: 貼壁生長;可適應(yīng)在無血清培養(yǎng)基中懸浮培養(yǎng)
親本系: 源自原始的 MDCK(馬-達(dá)二氏犬腎)細(xì)胞系
保藏機(jī)構(gòu): BioVector? ACC2219
2. 描述與應(yīng)用
BioVector? MDCK-33016 是一種經(jīng)認(rèn)證的連續(xù)細(xì)胞系,專門開發(fā)并篩選用于其對流感病毒的高敏感性。它是生產(chǎn)基于細(xì)胞的季節(jié)性和大流行性流感疫苗(例如商業(yè)疫苗 BioVector? Optaflu?)的關(guān)鍵底物。該細(xì)胞系支持人甲型和乙型流感病毒的高效分離和擴(kuò)增,與傳統(tǒng)的雞胚方法相比,通常表現(xiàn)出更高的分離率和與流行株更好的抗原匹配性。
3. 主要特征
高病毒產(chǎn)量: 經(jīng)改造以支持流感病毒的穩(wěn)健復(fù)制。
疫苗生產(chǎn): 用于生產(chǎn)細(xì)胞培養(yǎng)衍生的流感疫苗。
監(jiān)管認(rèn)可: 經(jīng)過驗(yàn)證,可用于人用疫苗生產(chǎn)。
安全性: 多重、正交的純化工藝確保去除殘留細(xì)胞和DNA,將理論風(fēng)險(xiǎn)降至實(shí)際上為零的水平。
4. 生長與培養(yǎng)條件
推薦培養(yǎng)基: BioVector? 高鹽 LB-Miller 培養(yǎng)基(用于相關(guān)細(xì)菌工作)或?qū)?BioVector? MDCK-33016 細(xì)胞優(yōu)化的特定無血清培養(yǎng)基。請注意,這些細(xì)胞需要1%的NaCl和特定的配方以達(dá)到最佳生長。
生長特性: 細(xì)胞以適用于疫苗生產(chǎn)的受控速率生長。貼壁培養(yǎng)需要標(biāo)準(zhǔn)的孵育條件(37°C,5% CO?)。
懸浮馴化: 該細(xì)胞系可使用適當(dāng)?shù)臒o血清培養(yǎng)基馴化為懸浮生長,便于大規(guī)模生物反應(yīng)器生產(chǎn)。

5. 質(zhì)量控制與安全性
無菌檢測: 細(xì)菌、真菌和支原體檢測均為陰性。
病毒檢測: 經(jīng)過廣泛檢測,確證無異源病毒因子和致癌病毒。
致瘤性: 與大多數(shù)連續(xù)細(xì)胞系一樣,它可在免疫缺陷小鼠體內(nèi)形成腫瘤,因此需要對最終產(chǎn)品進(jìn)行嚴(yán)格的純化。
6. 應(yīng)用
從臨床樣本中分離和擴(kuò)增流感病毒
生產(chǎn)細(xì)胞培養(yǎng)衍生的流感疫苗(季節(jié)性和大流行性)
候選疫苗病毒(CVV)的開發(fā)
用于流感病毒拯救的反向遺傳學(xué)系統(tǒng)
病毒學(xué)研究和診斷檢測

BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
電話:400-800-2947
工作QQ/微信同號:1843439339
網(wǎng)址 www.nedfriskphoto.com
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 MDCK-33016,MDCK-33016PF BioVector? cell line犬腎臟上皮細(xì)胞-流感病毒疫苗生產(chǎn)用細(xì)胞株 的詢問
- 公告/新聞




